Research progress and frontier trends in liver cancer immunotherapy in the post-COVID-19 era (2020–2024): a visualization analysis based on bibliometric methods
The COVID-19 pandemic has spurred multidisciplinary integration and the use of real-world evidence in research. Emerging themes like Sino-American collaboration, knowledge diffusion in core journals, and tumor microenvironment are shaping liver cancer immunotherapy research in the post-pandemic era. This study offers strategic insights for optimizing resources and advancing clinical-basic translational research.
Authors
- Jiawei Wang (ORCID: https://orcid.org/0000-0002-7663-5446)
- Yannan Xie (ORCID: https://orcid.org/0000-0002-6889-4288)
- Shicai Liang
- Xuebo Wang (ORCID: https://orcid.org/0000-0001-5552-1581)
- Jialong Wang (ORCID: https://orcid.org/0009-0008-9077-9068)
- Bendong Chen (ORCID: https://orcid.org/0000-0003-3908-8428)
- Xusheng Zhang (ORCID: https://orcid.org/0009-0009-3463-913X)
Institutions
- Ningxia Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1007/s12672-025-04144-0
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00